The Omaha, Neb.-based insurer follows BCBS of Michigan in covering the minimally invasive SI joint fusion using SI Bone’s iFuse device. The decision to cover the procedure was based on review of clinical literature scientifically validating iFuse’s use in the treatment of back pain.
Coverage was extended to 700,000 policyholders.
More articles about payer issues:
BCBS of Texas commits to offering ACA plans for 2017
House will vote on ACA individual mandate exemption bill
Aetna looks toward social programs for healthcare reform
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
